whea beadchip arrays (Bioarray Inc)
90
Structured Review
Bioarray Inc
whea beadchip arrays
Whea Beadchip Arrays, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whea+beadchip+array/hea+v1+2+beadchip+kit/pm31303508-43-12-15
Average 90 stars, based on 1 article reviews
Whea Beadchip Arrays, supplied by Bioarray Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whea+beadchip+array/hea+v1+2+beadchip+kit/pm31303508-43-12-15
Average 90 stars, based on 1 article reviews
whea beadchip arrays - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Mutagenesis:Article Title: Discrepancies between red cell phenotyping and genotyping in daily immunohematology laboratory practice. Article Snippet: RBC genotyping was performed using conventional PCR assays and wHEA, wRHD and Article Title: Evaluation of a red‐blood‐cell genotyping platform, ID CORE XT , within a hospital transfusion service Article Snippet: Received: 12 December 2018, revised 11 April 2019, accepted 25 April 2019 Background and Objectives Red-blood-cell genotyping is used to provide extended matched blood, resolve typing discrepancies and predict phenotype in recently transfused patients or patients with a positive direct antiglobulin test.. The aim of this study was to complete a performance and operational evaluation of a genotyping system, ID CORE XT (Progenika Biopharma–Grifols, Barcelona, Spain), within a hospital transfusion service, using the current genotyping method as a reference for comparison.. Materials and Methods DNA was extracted from blood donor and patient samples and tested using ID CORE XT and the reference method. Article Title: Abstracts of the 38th International Congress of the ISBT, Barcelona, Spain, 23-27 June 2024. Article Snippet: Methods: Immucor Article Title: Abstracts of the 38th International Congress of the ISBT, Barcelona, Spain, 23-27 June 2024. Article Snippet: Summary / Conclusions: c.137-8C>T GYPB mutation is known to affect the detection of the S antigen (GYPB c.143T) by the Article Title: Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience. Article Snippet: Background: The development of alloantibodies may complicate the management of patients with β-thalassemia.. An extended antigenic matching may reduce the risk of alloimmunization.. Our previous study showed that the introduction of molecular red blood cell (RBC) typing allows finding suitable blood units for multi-transfused patients. Article Title: Abstracts of the 38th International Congress of the ISBT, Barcelona, Spain, 23-27 June 2024. Article Snippet: Results: During a blood donor routine genotyping, we repeatedly had an indeterminate call (IC) for GYPB*S with the Article Title: Abstracts of the 38th International Congress of the ISBT, Barcelona, Spain, 23-27 June 2024. Article Snippet: Arnaud et al. (2013) described a novel GYPB mutation that induces a genotyping error or failure for GYPB*S with the Article Title: First report of a KELnull phenotype in Peru and a lesson of invisible genetic disparity. Article Snippet: Blood banks in developing countries have limited capability to typify common blood groups creating disparities in the access to blood units for patients with rare blood genotypes.. We report the case of a Peruvian woman with metastatic breast cancer with KELnull phenotype (K0), a rare blood group characterized by the lack of expression of all Kell antigens on the red blood cells (RBCs).. The molecular studies identified that the patient's RBCs were homozygous for the nonsense c.1546C > T mutation predicted to encode p.Arg516Ter (KEL*02 N.17 allele), which confirmed the K0 phenotype. |